secwatch.observer — SEC 8-K summary
======================================

Issuer:     COOPER COMPANIES, INC. (COO)
CIK:        0000711404
Form:       8-K
Filed at:   2026-09-09T20:34:31+00:00
Accession:  0001628280-26-061155
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CooperCompanies Q3 EPS $2.24 GAAP, $1.15 non-GAAP; completes strategic review, buyback to $3B
--------------------------------------------------------------------------------

- Revenue $1.066B, +1% YoY; GAAP EPS $2.24 (incl. $307.2M tax benefit), non-GAAP EPS $1.15 (+4%).
- Free cash flow $273M, +66% YoY; repurchased $339.1M of stock in Q3.
- Strategic review complete: Board unanimously retains CooperSurgical; buyback authorization raised from $2B to $3B.
- FY2026 guidance: revenue $4.229-4.252B, non-GAAP EPS $4.51-4.55; Q4 revenue $1.057-1.080B, non-GAAP EPS $1.05-1.09.
- CooperVision revenue flat at $717M; CooperSurgical revenue $349.2M, +2% (organic +3%).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/711404/000162828026061155/0001628280-26-061155-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/711404/000162828026061155/coo-20260909.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-061155

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer